IPSC
Century Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.11
+0.96%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- -$0.12
- Revenue estimate
- $1.6M
Latest reported
- Last report date
- Aug 12, 2026
- EPS actual
- -$0.17
- EPS estimate
- -$0.11
- Revenue actual
- —
- Revenue estimate
- $2.2M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 8
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 2
- Avg surprise (4Q)
- +1.0%
- Revenue beats (12Q)
- 4
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026